167 related articles for article (PubMed ID: 22434539)
1. FMS Kinase Inhibitors: Current Status and Future Prospects.
El-Gamal MI; Anbar HS; Yoo KH; Oh CH
Med Res Rev; 2013 May; 33(3):599-636. PubMed ID: 22434539
[TBL] [Abstract][Full Text] [Related]
2. Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging.
Jeffery JJ; Lux K; Vogel JS; Herrera WD; Greco S; Woo HH; AbuShahin N; Pagel MD; Chambers SK
Exp Biol Med (Maywood); 2014 Apr; 239(4):404-13. PubMed ID: 24599884
[TBL] [Abstract][Full Text] [Related]
3. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
Ohno H; Kubo K; Murooka H; Kobayashi Y; Nishitoba T; Shibuya M; Yoneda T; Isoe T
Mol Cancer Ther; 2006 Nov; 5(11):2634-43. PubMed ID: 17121910
[TBL] [Abstract][Full Text] [Related]
4. Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease.
Patel S; Player MR
Curr Top Med Chem; 2009; 9(7):599-610. PubMed ID: 19689368
[TBL] [Abstract][Full Text] [Related]
5. Growth and differentiation signals regulated by the M-CSF receptor.
Rohrschneider LR; Bourette RP; Lioubin MN; Algate PA; Myles GM; Carlberg K
Mol Reprod Dev; 1997 Jan; 46(1):96-103. PubMed ID: 8981370
[TBL] [Abstract][Full Text] [Related]
6. c-FMS inhibitors: a patent review.
Burns CJ; Wilks AF
Expert Opin Ther Pat; 2011 Feb; 21(2):147-65. PubMed ID: 21204725
[TBL] [Abstract][Full Text] [Related]
7. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
Rossner MT; McArthur GA; Allen JD; Metcalf D
Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
[TBL] [Abstract][Full Text] [Related]
8. M-CSF mediates TNF-induced inflammatory osteolysis.
Kitaura H; Zhou P; Kim HJ; Novack DV; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Dec; 115(12):3418-27. PubMed ID: 16294221
[TBL] [Abstract][Full Text] [Related]
9. M-CSF, c-Fms, and signaling in osteoclasts and their precursors.
Ross FP
Ann N Y Acad Sci; 2006 Apr; 1068():110-6. PubMed ID: 16831911
[TBL] [Abstract][Full Text] [Related]
10. Engineering a monomeric variant of macrophage colony-stimulating factor (M-CSF) that antagonizes the c-FMS receptor.
Zur Y; Rosenfeld L; Bakhman A; Ilic S; Hayun H; Shahar A; Akabayov B; Kosloff M; Levaot N; Papo N
Biochem J; 2017 Jul; 474(15):2601-2617. PubMed ID: 28655719
[TBL] [Abstract][Full Text] [Related]
11. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications.
Kumari A; Silakari O; Singh RK
Biomed Pharmacother; 2018 Jul; 103():662-679. PubMed ID: 29679908
[TBL] [Abstract][Full Text] [Related]
13. Transforming mechanism of the feline sarcoma virus encoded v-fms oncogene product.
Tamura T; Hadwiger-Fangmeier A; Simon E; Smola U; Geschwill H; Schütz B; Trouliaris S; Boscheck B; Niemann H; Bauer H
Behring Inst Mitt; 1991 Jul; (89):93-9. PubMed ID: 1834054
[TBL] [Abstract][Full Text] [Related]
14. CSF-1 signal transduction.
Hamilton JA
J Leukoc Biol; 1997 Aug; 62(2):145-55. PubMed ID: 9261328
[TBL] [Abstract][Full Text] [Related]
15. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation.
Chihara T; Suzu S; Hassan R; Chutiwitoonchai N; Hiyoshi M; Motoyoshi K; Kimura F; Okada S
Cell Death Differ; 2010 Dec; 17(12):1917-27. PubMed ID: 20489731
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a new potent bisamide FMS kinase inhibitor.
El-Gamal MI; Jung MH; Oh CH
Bioorg Med Chem Lett; 2010 Jun; 20(11):3216-8. PubMed ID: 20457522
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors.
El-Gamal MI; Al-Ameen SK; Al-Koumi DM; Hamad MG; Jalal NA; Oh CH
J Med Chem; 2018 Jul; 61(13):5450-5466. PubMed ID: 29293000
[TBL] [Abstract][Full Text] [Related]
18. The colony-stimulating factor 1 (CSF-1) receptor (c-fms proto-oncogene product) and its ligand.
Rettenmier CW; Roussel MF; Sherr CJ
J Cell Sci Suppl; 1988; 9():27-44. PubMed ID: 2978516
[TBL] [Abstract][Full Text] [Related]
19. Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway.
Le Meur Y; Tesch GH; Hill PA; Mu W; Foti R; Nikolic-Paterson DJ; Atkins RC
J Leukoc Biol; 2002 Sep; 72(3):530-7. PubMed ID: 12223521
[TBL] [Abstract][Full Text] [Related]
20. c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms.
Mancini A; Koch A; Wilms R; Tamura T
J Biol Chem; 2002 Apr; 277(17):14635-40. PubMed ID: 11847211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
